URGN UroGen Pharma Ltd. logo

URGN UroGen Pharma Ltd.

Healthcare
$28.89-3.31%ClosedMarket Cap: $1.41B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

175

13F Shares

43,711,456

Ownership %

91.0%

New Positions

30

Increased Positions

79

Closed Positions

24

Reduced Positions

56

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
IZRLARK Israel Innovative Technology ETF115,5451.64%
CANCTema Oncology ETF72,3780.78%
ITEQAmplify BlueStar Israel Technology ETF30,0970.50%
ANOGX653,0420.31%
VEVFX71,5690.17%
IJE101,4360.15%
IWCiShares Micro-Cap ETF101,4360.15%
VFMO70,0350.14%
IBBiShares Biotechnology ETF286,0410.06%
FESMFidelity Enhanced Small Cap ETF123,3010.05%
VTWG27,7200.04%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF21,6900.04%
IWOiShares Russell 2000 Growth ETF270,2250.04%
NLO270,2250.04%
GWXState Street SPDR S&P International Small Cap ETF17,2790.04%
RSSLGlobal X - Russell 2000 ETF16,8660.03%
VTWO182,9170.03%
NJM977,4910.02%
IWMiShares Russell 2000 ETF977,4910.02%
VHT118,1860.01%